Clinical Trial Update: Efficacy and Safety of CDOP vs CHOP for Newly Diagnosed Peripheral T-cell Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing CDOP to CHOP for newly diagnosed peripheral T-cell lymphoma is being reported, focusing on efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• CDOP
• CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)

Snippet

Sponsor: Peking University | Conditions: Peripheral T-cell Lymphoma | Phase 3 | Status: UNKNOWN